Quality problems in clinical practice guidelines and guideline appraisal studies: Should we tolerate or eradicate?

Guo‐Xun Yang,Shu‐Qian Dou,Xiao‐Bo Liu,Ting Que,Yong Tang,Xin Wang,Long‐Zong Yan,Li‐Na Zhou,Cheng‐Bo Jin,Yuan Wang,Qi Wang,Kong‐Jia Wu,Wen‐Jun Liu
DOI: https://doi.org/10.1111/jep.14227
2024-10-31
Journal of Evaluation in Clinical Practice
Abstract:Background Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument have been widely used by scholars around the world to assess the methodological quality of clinical practice guidelines (CPGs). We sought to identify items or domains that are commonly scored low in the assessment, and to systematically review the issues that emerged when evaluators used the AGREE II tool for guideline quality assessment. Methods A systematic search was conducted to identify articles published in medically relevant databases from 2022 to 2023 regarding the use of the AGREE II tool for the assessment of CPGs. We extracted six quality domains and overall quality assessment data of CPGs included in the literature, and processed the data using descriptive statistical analysis, difference analysis, regression analysis, and correlation analysis. A seven‐point Likert scale was used to assess the reporting quality of the included articles. Results 151 relevant publications were identified, including 2081 guidelines published between 1990 and 2022. The results of the regression analysis showed a statistically significant impact of all domains on overall guideline quality (p
medicine, general & internal,health care sciences & services,medical informatics
What problem does this paper attempt to address?